Abstract Number: 535 • 2012 ACR/ARHP Annual Meeting
Reduced Joint Counts Misclassify Psoriatic Arthritis Patients with Oligoarthritis and Miss Significant Active Disease
Background/Purpose: Despite recommendations to use full joint counts to assess patients with PsA, reduced joint counts designed for RA are often used for reporting outcomes…Abstract Number: 536 • 2012 ACR/ARHP Annual Meeting
Psoriasis and Psoriatic Arthritis in a Diverse Ethnic Cohort
Background/Purpose: Few clinical studies describe psoriasis (PSO) and psoriatic arthritis (PsA) in ethnic minority groups. Previous patient-reported data show PSO/PsA to be less frequent in…Abstract Number: 537 • 2012 ACR/ARHP Annual Meeting
The Association of alpha7 Nicotinic Acetylcholine Receptor Polymorphisms with Psoriatic Arthritis and Its Interaction with Smoking
Background/Purpose: Alpha7 nicotinic acetylcholine receptor (CHRNA7) is an ion channel that is gated by the binding of nicotinic ligands. Nicotine interacts with CHRNA7 leading to…Abstract Number: 538 • 2012 ACR/ARHP Annual Meeting
Association Between Biomarkers (Metalloproteinase-3, Dikkopf-1 and Sclerostin) with Disease Activity and Prediction of Anti-TNFá Therapy Response in Patients with Ankylosing Spondylitis
Background/Purpose: Better objectives measures for evaluating disease activity and anti-TNFα response in patients with ankylosing spondylitis (AS) are needed. MMP-3 seems to be the most…Abstract Number: 539 • 2012 ACR/ARHP Annual Meeting
Efficacy and Safety of Adalimumab for the Treatment of Peripheral Arthritis in Spondyloarthritis Patients without Ankylosing Spondylitis or Psoriatic Arthritis
Background/Purpose: The treatment of spondyloarthritis (SpA) has improved dramatically since the introduction of TNF-blockade. However, this therapy is only approved and reimbursed for the treatment…Abstract Number: 540 • 2012 ACR/ARHP Annual Meeting
The Predictors of Reduced Work Productivity in Patients with Psoriatic Arthritis
Background/Purpose: Psoriatic arthritis (PsA) is a unique inflammatory musculoskeletal disorder associated with psoriasis. Related to its detrimental impact on health and quality of life, PsA…Abstract Number: 541 • 2012 ACR/ARHP Annual Meeting
Prevalence of Sacroiliitis in the General Population: Comparative Analysis with Cutaneous Psoriasis and Psoriatic Arthritis
Background/Purpose: At least grade 2 unilateral sacroiliitis in the presence of spinal symptoms (defined as a combination of inflammatory back pain plus back stiffness) in…Abstract Number: 542 • 2012 ACR/ARHP Annual Meeting
Validation of a Reference Imaging Module for Calibration of Readers Scoring with the Modified Stoke Ankylosing Spondylitis Spine Score
Background/Purpose: The modified Stoke Ankylosing Spondylitis Spine Score (mSASSS) is used to assess progression in AS based on the lateral spinal radiograph but the methodology…Abstract Number: 543 • 2012 ACR/ARHP Annual Meeting
Wnt Pathway Inhibitors in Patients with Psoriatic and Rheumatoid Arthritis Treated with Anti-TNF Therapy
Background/Purpose: Both rheumatoid arthritis (RA) and psoriatic arthritis (PsA) are characterised by bone erosion but aberrant bone formation is also a feature in PsA. Wnt…Abstract Number: 544 • 2012 ACR/ARHP Annual Meeting
Anterior Chest Wall Pain in Recent Inflammatory Back Pain. Data From the DESIR Cohort
Background/Purpose: Anterior chest wall pain (ACW) may be suggestive of spondyloarthritis (SpA), but little is known about this clinical feature in recent inflammatory back pain…Abstract Number: 545 • 2012 ACR/ARHP Annual Meeting
Correlates of Inflammatory Back Pain in a Nationally Representative Sample of the US Population
Background/Purpose: There are no published studies on correlates of inflammatory back pain (IBP) based on a large-scale nationally representative sample. In the present study, we…Abstract Number: 546 • 2012 ACR/ARHP Annual Meeting
The Immunogenicity to the First Anti-TNF Therapy Determines the Outcome of Switching to a Second Anti-TNF in Spondyloarthritis Patients
Background/Purpose: Spondyloarthropathies (SpAs) encompass a heterogeneous group of diseases that primarily affect the axial skeleton and entheses. Although anti-TNF drugs have proven to be effective…Abstract Number: 547 • 2012 ACR/ARHP Annual Meeting
Comparison and Validation of Screening Questionnaires for Psoriatic Arthritis in Patients with Psoriasis
Background/Purpose: Several self-administered screening questionnaires are available to identify patients suspected as suffering from psoriatic arthritis (PsA) among patients with psoriasis, thus facilitating their referral…Abstract Number: 548 • 2012 ACR/ARHP Annual Meeting
Assessment of the T1-Weighted Sequence Is Essential in Defining a Positive MRI Scan of the Sacroiliac Joints in Spondyloarthritis
Background/Purpose: Inflammation on MRI of the sacroiliac joints (SIJ) in patients with spondyloarthritis (SpA) is a major criterion in the Assessment of SpondyloArthritis (ASAS) classification…Abstract Number: 549 • 2012 ACR/ARHP Annual Meeting
A Randomized, Open-Label Study of Maintenance of Partial Remission with Naproxen Vs No Treatment: Results of the Infliximab As First Line Therapy in Patients with Early Active Axial Spondyloarthritis Trial, Part II
Background/Purpose: In patients with axial SpA who have achieved partial remission, it is unclear whether continuous treatment with NSAIDs is superior to stopping treatment. Objectives:…